Patient recruitment technology provider grew sales by 90%, revenue by 60%, and team by 35% despite challenging industry environment

CHAPEL HILL, N.C., and MALMÖ, Sweden — February 28, 2024 — Trialbee, the global leader in technology-based patient recruitment for clinical trials, announced that it increased global sales by approximately 90%, revenue by 60%, and its team by 35% despite a challenging industry environment in 2023. Growth was primarily driven by enhancements to its flagship Honey Platform™, continued differentiation of its Precision Recruitment solution featuring hyper-targeted digital marketing with two-step medical pre-qualification, and new Omnichannel Network partnerships to expand patient pathways.

Trialbee, which rebranded late in the year to focus on its core value, aims to capitalize on this strong momentum by accelerating enterprise-wide SaaS adoption of its Honey Platform among top pharmaceutical companies in 2024. The company will also tailor its combined solution offering, including proven partnerships, for key therapeutic areas while emphasizing its trademark focus on data-driven recruitment of ideal participant profiles. As the team continues to grow globally, Trialbee is committed to its culture of being humble, kind, curious, and fun.

“2023 was a big step forward for our team and, more importantly, validation of by our customers and site users that the strategy we embarked on three years ago is unique, valuable, and exciting,” said Matt Walz, Trialbee CEO. “We built the Honey Platform and surrounded it with the best and most experienced patient recruitment leaders in our industry – then enhanced our service offerings by creating real relationships with proven partners who can expand the funnel alongside our own Precision Recruitment services. This model represents a totally new and fresh approach to global recruitment, and it is clearly resonating with our customers, sites, and most importantly patients themselves.”

“The Honey Platform is the only stand-alone and vendor-agnostic SaaS solution developed with actual patient recruitment experts,” said Martin Kilsgard, Head of Product at Trialbee. “While always guided by site and study team users, it was built and continues to be developed to meet the needs of our most demanding customer – our own internal Trialbee Precision Recruitment team that uses it every day to manage customer success across dozens of trials, countries, patient populations, and therapeutic areas. For the first time in our industry, Honey’s ability to deliver total visibility into the recruitment funnel, from initial outreach to enrollment, provides customers with total control over their global patient recruitment results.”

Highlights from Trialbee’s rapid growth in 2023 included…

  • Launch of the Omnichannel Connector, an open API integration to centralize activity from all recruitment sources, with standardized data formats, in a single platform
  • Enhanced ROI reporting features to provide unprecedented transparency into results by provider, patient advocacy group, and tactical channel
  • Rebranded the company around a new vision for global patient recruitment ecosystem
  • Added 12 new major pharmaceutical companies to its customer roster along with 7 new strategic CRO preferred partnerships
  • Announcing Omnichannel Network collaborations with proven organizations such as Acclinate, Savvy Cooperative, and MassiveBio
  • Sponsored conference sessions, hosted educational webinars, and published content focused on the importance and emerging role of technology in patient recruitment

To request a demonstration of the Honey Platform and learn how it can transform trial design and patient recruitment for your clinical trials, visit

About Trialbee

Trialbee is revolutionizing the patient recruitment ecosystem with technology, people, and passion. The company’s vendor-agnostic Honey Platform™ is a SaaS Patient Recruitment Platform that centralizes and standardizes all recruitment activities from every source, channel, and partner from interest through enrollment — providing unprecedented transparency and actionable insights for real-time patient tracking, higher-quality referrals that reduce site burden, and robust ROI reporting. Honey is surrounded by a team of Precision Recruitment experts who meet patients where they are in their journey with data-driven modeling based on consumer behavior and other real-world data, hyper-targeted digital outreach, two-step pre-qualification, and meaningful Omnichannel partners focused on patient advocacy, community engagement, and diversity. To take control of patient recruitment for your next study, visit


Matt McLoughlin
Gregory FCA (for Trialbee)